RPLP1 and breast carcinoma: When CtE values from ERα+ breast cancer cell lines were supplied, RPLP1 was again ranked top RG candidate with the least variability in expression, according to RefFinder, BestKeepeer and the comparative ΔCt method (Supplementary Table S5, Fig. 3B).